X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-01-03 | CMMB | Orbimed Israel Gp Ltd. | 10% | S - Sale | $3.58 | -336,900 | 2,241,274 | -13% | -$1,207,759 | ||||||
| D | 2023-01-03 | CMMB | Mor George Adi | Chief Scientific Officer | S - Sale+OE | $5.03 | -13,800 | 568,222 | -2% | -$69,370 | |||||
| D | 2022-11-16 | CMMB | Cohen Neil Harris | Dir | S - Sale+OE | $2.00 | -2,409 | 10,000 | -19% | -$4,818 | |||||
| D | 2022-11-16 | CMMB | Mor George Adi | Chief Scientific Officer | S - Sale+OE | $2.08 | -582,023 | 582,022 | -50% | -$1,213,402 | |||||
| D | 2022-03-16 | CMMB | Marvin Donald | EVP, CFO, COO | P - Purchase | $3.28 | +500 | 2,000 | +33% | +$1,638 | |||||
| D | 2022-05-24 | CMMB | Maryles Joel Michael | Dir | P - Purchase | $2.88 | +433 | 1,433 | +43% | +$1,247 | |||||
| D | 2022-05-18 | CMMB | Cohen Neil Harris | Dir | P - Purchase | $3.19 | +2,000 | 12,409 | +19% | +$6,380 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |